{"product_id":"lactulose-syrup-200-hepatic-encephalopathy","title":"MIP lactulose syrup, hepatic encephalopathy 200","description":"\u003ch1 class=\"projector_description description\"\u003eMIP lactulose syrup 200ml, hepatic encephalopathy\u003c\/h1\u003e\n\u003cdiv class=\"projector_description description\"\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLactulose\u003c\/strong\u003e is used as a medicament constipation and laxative in the prevention and treatment of hepatic encephalopathy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"component_projector_longdescription\"\u003e\n\u003cdiv class=\"n56174_main\"\u003e\n\u003ch2\u003e\u003cstrong\u003eThe composition of the MIP lactulose syrup, hepatic encephalopathy:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003e15 ml of syrup contains the active substance: 9.75 g (Lactulosum) lactulose\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunctional Description:\u003cbr\u003e\u003c\/strong\u003eThe product with mild laxative. Disaccharide lactulose is non-digestible and absorbed in the small intestine. In the large intestine, where it is a medium for saccharolytic bacteria is degraded into shorter chain fatty acids, above all lactic acid and acetic acid, and methane and hydrogen. Lowering the pH and the osmotic effect of the stimulus to accelerate peristalsis. The formulation also reduces the absorption of ammonium ions and other toxic nitrogen compounds. Laxative effect usually occurs after 1-2 days after taking the full dose.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIndications for use:\u003cbr\u003e\u003c\/strong\u003eConstipation. Prevention and treatment of hepatic encephalopathy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eContraindications:\u003cbr\u003e\u003c\/strong\u003eSyrup should not be used in case of hypersensitivity to lactulose or any of the other ingredients, intestinal obstruction, gastrointestinal inflammation and disorders of fluid and electrolyte. It should not be used in patients with hereditary fructose intolerance, impaired secretion of lactase, with galactosemia or impaired intestinal absorption of glucose and galactose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eDosage MIP lactulose syrup, hepatic encephalopathy and administration:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003eSyrup should be taken orally. Doses should be adjusted to the patient, the severity and course of the disease. Dosing syrup is included with the package scoop. constipation\u003c\/p\u003e\n\u003cp\u003eAdults: 10 to 15 ml Syrup (6 to 10g) 1 to 2 times a day. Children: depending on the age of 5 to 10 ml Lactulose-MIP (3 to 6 g lactulose) 1 to 2 times a day. Hepatic encephalopathy . doses should be increased gradually. Adults: initially 10 to 15ml of syrup lactulose-MIP (6 to 10g of lactulose) 3 times a day, then increased to 30-40 ml syrup lactulose-MIP (20 to 30 g lactulose) 3 to 4 times day.Dosage should be adjusted to the patient defecate loose stool 2 to 3 times a day.\u003c\/p\u003e\n\u003ch1 class=\"product-single__title\" itemprop=\"name\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003eMIP lactulose syrup, hepatic encephalopathy\u003c\/span\u003e\u003c\/h1\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Mip Pharma","offers":[{"title":"Default Title","offer_id":54932231127417,"sku":"MIP lactulose syrup 200ml","price":26.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0903\/0792\/0249\/files\/mip-lactulose-syrup-hepatic-encephalopathy-uk-1.jpg?v=1738885125","url":"https:\/\/ukdorf.co.uk\/products\/lactulose-syrup-200-hepatic-encephalopathy","provider":"UKDorf (ELIVERA) Buy online, Reviews Est. 1988 London, UK.","version":"1.0","type":"link"}